A Concise and Practical Semisynthesis of Ecteinascidin 743 and (–)‐Jorumycin
Shanghu Xu,Guan Wang,Jinjin Zhu,Chuang Shen,Zhezhou Yang,Jun Yu,Zhong Li,Tanghuan Lin,Xun Sun,Fuli Zhang
DOI: https://doi.org/10.1002/ejoc.201601409
IF: 3.261
2017-01-01
European Journal of Organic Chemistry
Abstract:Ecteinascidin 743 is an antitumor drug used to treat specific soft‐tissue sarcomas (STS). In this paper, we present a concise and practical semisynthesis of ecteinascidin 743 starting from safracin B. The strategy involves the direct conversion of an aliphatic amino group into an acetoxy group. By this approach, ecteinascidin 743 was synthesized in 14 steps and 1.5 % overall yield. The synthetic approach also provided access to other tetrahydroisoquinoline alkaloids, such as (–)‐jorumycin (a promising anticancer candidate). (–)‐Jorumycin was prepared in six steps and 24.1 % overall yield from safracin B.